Literature DB >> 26767017

β-elemene reverses the drug resistance of A549/DDP lung cancer cells by activating intracellular redox system, decreasing mitochondrial membrane potential and P-glycoprotein expression, and inducing apoptosis.

Chengcai Yao1, Jie Jiang2, Yuanrong Tu3, Shefang Ye4, Haoxin Du5, Yi Zhang5.   

Abstract

BACKGROUND: β-elemene (β-ELE) injection is a new anticancer drug extracted from Curcuma zedoaria Roscoe that has been widely used to treat malignant tumors. Recent studies show that β-ELE reverses the drug resistance of tumor cells. To explore the possible mechanisms of β-ELE, we investigated its effects on cisplatin (DDP)-resistant human lung adenocarcinoma A549/DDP cells.
METHODS: The effects of β-ELE on the growth of A549/DDP cells in vitro were determined by MTT assay. Apoptosis was assessed by fluorescence microscopy with Hoechst 33258 staining, flow cytometry with Annexin V-FITC/propium iodide double staining; mitochondrial membrane potential using JC-1 fluorescence probe and laser confocal scanning microscopy, and intracellular reactive oxygen species levels were measured by 2',7'-dichlorfluorescein-diacetate staining and flow cytometry; and contents of cytosolic glutathione were determined by glutathione assay kits. Intracellular Rhodamine-123 fluorescence intensity was detected by flow cytometry, and the expression of P-glycoprotein (P-gp) was detected by Western blotting.
RESULTS: β-ELE inhibited the proliferation of A549/DDP cells in a time- and dose-dependent manner. Furthermore, β-ELE enhanced the sensitivity of A549/DDP cells to cisplatin and reversed the drug resistance of A549/DDP cells. Consistent with a role in activating apoptosis, β-ELE decreased mitochondrial membrane potential, increased intracellular reactive oxygen species concentration and intracellular accumulation of Rhodamine-123, decreased the cytoplasmic glutathione levels and the expression of P-gp in a time- and dose-dependent manner.
CONCLUSIONS: These results define a pathway of β-ELE function that involves decreased mitochondrial membrane potential and P-gp expression activated intracellular redox system, and induced apoptosis leading to reverse drug resistance.

Entities:  

Keywords:  A549/DDP cell; apoptosis; drug resistance; elemene; lung neoplasms

Year:  2014        PMID: 26767017      PMCID: PMC4704358          DOI: 10.1111/1759-7714.12093

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  20 in total

1.  [Neoadjuvant chemotherapy and surgical treatment in advanced stages of non-small cell lung cancer].

Authors:  M Szkorupa; J Klein; T Bohanes; C Neoral; V Kolek; I Grygárková
Journal:  Rozhl Chir       Date:  2011-08

Review 2.  [Molecular aspects of apoptosis].

Authors:  Nikola Radović; Snjezana Cucić; Silvio Altarac
Journal:  Acta Med Croatica       Date:  2008-07

3.  [Treatment outcome of locally advanced stage IIIA/B lung cancer].

Authors:  Saulius Cicenas; Aurelija Zaliene; Vydmantas Atkocius
Journal:  Medicina (Kaunas)       Date:  2009       Impact factor: 2.430

4.  Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells.

Authors:  Qingdi Quentin Li; Rebecca X Lee; Huasheng Liang; Yuhua Zhong; Eddie Reed
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

5.  Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors.

Authors:  Sarah B Goldberg; Geoffrey R Oxnard; Subba Digumarthy; Alona Muzikansky; David M Jackman; Inga T Lennes; Lecia V Sequist
Journal:  Oncologist       Date:  2013-09-26

6.  Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.

Authors:  T Nakamura; M Oka; K Aizawa; H Soda; M Fukuda; K Terashi; K Ikeda; Y Mizuta; Y Noguchi; Y Kimura; T Tsuruo; S Kohno
Journal:  Biochem Biophys Res Commun       Date:  1999-02-24       Impact factor: 3.575

7.  β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter.

Authors:  Hui-Qin Guo; Guan-Nan Zhang; Yi-Jun Wang; Yun-Kai Zhang; Kamlesh Sodani; Tanaji T Talele; Charles R Ashby; Zhe-Sheng Chen
Journal:  Oncol Rep       Date:  2013-11-27       Impact factor: 3.906

8.  Clinical significance of heterogeneity in response to retreatment with epidermal growth factor receptor tyrosine kinase inhibitors in patients with lung cancer acquiring secondary resistance to the drug.

Authors:  Youngjoo Lee; Hyae Young Kim; Soo-Hyun Lee; Kun Young Lim; Geon Kook Lee; Tak Yun; Ji-Youn Han; Heung Tae Kim; Jin Soo Lee
Journal:  Clin Lung Cancer       Date:  2013-11-14       Impact factor: 4.785

9.  1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell lines.

Authors:  Jun Hong; Ismael Samudio; Sudhakar Chintharlapalli; Stephen Safe
Journal:  Mol Carcinog       Date:  2008-07       Impact factor: 4.784

10.  [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP].

Authors:  Jie Lv; Yufeng Tian
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-09
View more
  13 in total

1.  Preliminary evaluation of the potential role of β-elemene in reversing erlotinib-resistant human NSCLC A549/ER cells.

Authors:  Lan Lin; Lianbin Li; Xiangqi Chen; Bangwei Zeng; Tingyan Lin
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

2.  Quantification of mitochondrial membrane potential in the isolated rat lung using rhodamine 6G.

Authors:  Said H Audi; Anthony Cammarata; Anne V Clough; Ranjan K Dash; Elizabeth R Jacobs
Journal:  J Appl Physiol (1985)       Date:  2020-03-05

Review 3.  Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.

Authors:  J Wei; Z Liu; J He; Q Liu; Y Lu; S He; B Yuan; J Zhang; Y Ding
Journal:  Clin Transl Oncol       Date:  2021-10-13       Impact factor: 3.405

4.  Ultraviolet light-emitting diode irradiation induces reactive oxygen species production and mitochondrial membrane potential reduction in HL-60 cells.

Authors:  Dong Xie; Yun-Long Li; Gui-Fen Wang; Jian Jiang; Li-Rong Sun
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

5.  Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway.

Authors:  Ping Zhang; Yang Zhang; Kuikui Liu; Bin Liu; Wenping Xu; Jufang Gao; Lei Ding; Liming Tao
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

6.  Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia.

Authors:  Kambere Amerigos Daddy J C; Minglei Chen; Faisal Raza; Yanyu Xiao; Zhigui Su; Qineng Ping
Journal:  Pharmaceutics       Date:  2020-02-23       Impact factor: 6.321

7.  The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene.

Authors:  Shuiping Liu; Qiujie Li; Guohua Li; Qin Zhang; Lvjia Zhuo; Xuemeng Han; Mingming Zhang; Xiaying Chen; Ting Pan; Lili Yan; Ting Jin; Jianjun Wang; Qun Lv; Xinbing Sui; Tian Xie
Journal:  Cell Death Dis       Date:  2020-11-11       Impact factor: 8.469

8.  Extract of Curcuma zedoaria R. prevents atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Ki Mo Kim; Joo Young Lee; Byeong Hwa Jeon; Khong Trong Quan; MinKyun Na; Kung-Woo Nam; Sungwook Chae
Journal:  Nutr Res Pract       Date:  2021-02-05       Impact factor: 1.926

Review 9.  The Antitumor Efficacy of β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment.

Authors:  Qiang Xie; Fengzhou Li; Lei Fang; Wenzhi Liu; Chundong Gu
Journal:  Biomed Res Int       Date:  2020-02-19       Impact factor: 3.411

Review 10.  Anti-Tumor Drug Discovery Based on Natural Product β-Elemene: Anti-Tumor Mechanisms and Structural Modification.

Authors:  Ziqiang Bai; Chuansheng Yao; Junlong Zhu; Yuanyuan Xie; Xiang-Yang Ye; Renren Bai; Tian Xie
Journal:  Molecules       Date:  2021-03-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.